Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthetic Biology02:55

Synthetic Biology

4.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
4.7K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Hybridoma Technology01:31

Hybridoma Technology

14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Essential nucleus-apical pole linkage maintains division fidelity during Plasmodium progeny formation.

The EMBO journal·2026
Same author

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

Nature cancer·2026
Same author

DNA origami snaps into place.

Science robotics·2026
Same author

Volume and surface methods for microparticle traction force microscopy: a computational and experimental comparison.

Soft matter·2026
Same author

Stress granule phase separation in stress-responsive cytosolic extract-in-oil droplets.

Nature communications·2026
Same author

Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial.

Nature cancer·2026

Related Experiment Video

Updated: Jun 15, 2025

Synthetic Antigen Controls for Immunohistochemistry
09:30

Synthetic Antigen Controls for Immunohistochemistry

Published on: August 23, 2021

2.5K

Bottom-up synthetic immunology.

Kerstin Göpfrich1,2, Michael Platten3,4,5,6, Friedrich Frischknecht7,8

  • 1Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg University, Heidelberg, Germany. k.goepfrich@zmbh.uni-heidelberg.de.

Nature Nanotechnology
|August 26, 2024
PubMed
Summary
This summary is machine-generated.

Synthetic immunology offers novel strategies for treating cancer and infectious diseases by engineering immune cells. A bottom-up approach using nanotechnology shows promise for targeted therapies and prevention.

More Related Videos

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer
09:37

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer

Published on: April 27, 2020

11.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K

Related Experiment Videos

Last Updated: Jun 15, 2025

Synthetic Antigen Controls for Immunohistochemistry
09:30

Synthetic Antigen Controls for Immunohistochemistry

Published on: August 23, 2021

2.5K
Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer
09:37

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer

Published on: April 27, 2020

11.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K

Area of Science:

  • Immunology
  • Synthetic Biology
  • Nanotechnology

Background:

  • Infectious diseases and cancer share immune evasion mechanisms, suggesting common therapeutic targets.
  • Synthetic immunology applies engineering principles to immunology for novel treatment strategies.
  • Current genetic immune engineering (top-down) is largely ex vivo and faces immune counter-regulation challenges.

Purpose of the Study:

  • To conceptualize bottom-up synthetic immunology as a frontier field.
  • To explore nanotechnology's role in developing targeted immune interventions.
  • To highlight innovations in preventing and treating cancer and infectious diseases.

Main Methods:

  • Reviewing successes of top-down synthetic immunology (genetic engineering).
  • Exploring bottom-up synthetic biology using nanotechnology and nanoscale building blocks.
  • Conceptualizing rational design of molecular and cellular systems for immune functions.

Main Results:

  • Top-down synthetic immunology has shown success in treating advanced cancers.
  • Bottom-up synthetic biology offers a new approach to engineer immune systems from scratch.
  • Nanotechnology enables the creation of tailored systems for targeted immune functions.

Conclusions:

  • Bottom-up synthetic immunology, leveraging nanotechnology, represents a promising new frontier.
  • This approach facilitates rational design for targeted immune functions.
  • Innovations in bottom-up synthetic immunology can advance therapy and prevention for cancer and infectious diseases.